Literature DB >> 22441102

Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Delphine Eberlé1, Roy Y Kim, Fu Sang Luk, Nabora Soledad Reyes de Mochel, Nathalie Gaudreault, Victor R Olivas, Nikit Kumar, Jessica M Posada, Andrew C Birkeland, Joseph H Rapp, Robert L Raffai.   

Abstract

OBJECTIVE: Apolipoprotein (apo) E4 is an established risk factor for atherosclerosis, but the structural components underlying this association remain unclear. ApoE4 is characterized by 2 biophysical properties: domain interaction and molten globule state. Substituting Arg-61 for Thr-61 in mouse apoE introduces domain interaction without molten globule state, allowing us to delineate potential proatherogenic effects of domain interaction in vivo. METHODS AND
RESULTS: We studied atherosclerosis susceptibility of hypomorphic Apoe mice expressing either Thr-61 or Arg-61 apoE (ApoeT(h/h) or ApoeR(h/h)mice). On a chow diet, both mouse models were normolipidemic with similar levels of plasma apoE and lipoproteins. However, on a high-cholesterol diet, ApoeR(h/h) mice displayed increased levels of total plasma cholesterol and very-low-density lipoprotein as well as larger atherosclerotic plaques in the aortic root, arch, and descending aorta compared with ApoeT(h/h) mice. In addition, evidence of cellular dysfunction was identified in peritoneal ApoeR(h/h) macrophages which released lower amounts of apoE in culture medium and displayed increased expression of major histocompatibility complex class II molecules.
CONCLUSIONS: These data indicate that domain interaction mediates proatherogenic effects of apoE4 in part by modulating lipoprotein metabolism and macrophage biology. Pharmaceutical targeting of domain interaction could lead to new treatments for atherosclerosis in apoE4 individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441102      PMCID: PMC3346714          DOI: 10.1161/ATVBAHA.112.246389

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  38 in total

1.  Evidence for differential effects of apoE3 and apoE4 on HDL metabolism.

Authors:  Paul C R Hopkins; Yadong Huang; James G McGuire; Robert E Pitas
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

2.  Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E.

Authors:  R L Raffai; L M Dong; R V Farese; K H Weisgraber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism.

Authors:  Robert L Raffai; Karl H Weisgraber
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

4.  APOE ε3 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions.

Authors:  Hong-Liang Zhang; Xi-Jing Mao; Xing-Mei Zhang; Hai-Feng Li; Xiang-Yu Zheng; Abdu Adem; Eilhard Mix; Jie Zhu
Journal:  Exp Neurol       Date:  2011-04-30       Impact factor: 5.330

5.  Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.

Authors:  Masumi Hara; Teruhiko Matsushima; Hiroaki Satoh; Naoyuki Iso-o; Hiroshi Noto; Masako Togo; Satoshi Kimura; Yoshiaki Hashimoto; Kazuhisa Tsukamoto
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 6.  Association of apolipoprotein E genotypes with lipid levels and coronary risk.

Authors:  Anna M Bennet; Emanuele Di Angelantonio; Zheng Ye; Frances Wensley; Anette Dahlin; Anders Ahlbom; Bernard Keavney; Rory Collins; Björn Wiman; Ulf de Faire; John Danesh
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

7.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

8.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

9.  Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice.

Authors:  Ning Zhong; Kimberly Scearce-Levie; Gayathri Ramaswamy; Karl H Weisgraber
Journal:  Alzheimers Dement       Date:  2008-05       Impact factor: 21.566

10.  Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease.

Authors:  Julie A Morrow; Danny M Hatters; Bin Lu; Peter Hochtl; Keith A Oberg; Bernhard Rupp; Karl H Weisgraber
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

View more
  11 in total

1.  Progranulin in the hematopoietic compartment protects mice from atherosclerosis.

Authors:  Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese
Journal:  Atherosclerosis       Date:  2018-08-30       Impact factor: 5.162

2.  Hyperglycemia impairs atherosclerosis regression in mice.

Authors:  Nathalie Gaudreault; Nikit Kumar; Victor R Olivas; Delphine Eberlé; Kyle Stephens; Robert L Raffai
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

3.  Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress.

Authors:  James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui
Journal:  J Biol Chem       Date:  2012-06-23       Impact factor: 5.157

4.  ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

5.  Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

Authors:  Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

6.  Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy.

Authors:  Emily J Koller; Elsa Gonzalez De La Cruz; Mary Weinrich; Tosha Williams; Pedro E Cruz; Daniel Ryu; Todd E Golde; Patrick M Sullivan; Jada Lewis; David R Borchelt; Paramita Chakrabarty
Journal:  Mol Neurobiol       Date:  2020-01-06       Impact factor: 5.590

Review 7.  Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation.

Authors:  Laura Bouchareychas; Robert L Raffai
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-23

8.  Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.

Authors:  David Nguyen; Padmaja Dhanasekaran; Margaret Nickel; Chiharu Mizuguchi; Mayu Watanabe; Hiroyuki Saito; Michael C Phillips; Sissel Lund-Katz
Journal:  Biochemistry       Date:  2014-06-24       Impact factor: 3.162

Review 9.  APOE genotype and stress response - a mini review.

Authors:  Janina Dose; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2016-07-25       Impact factor: 3.876

10.  Genetic variants of ApoE and ApoER2 differentially modulate endothelial function.

Authors:  Victoria Ulrich; Eddy S Konaniah; Joachim Herz; Robert D Gerard; Eunjeong Jung; Ivan S Yuhanna; Mohamed Ahmed; David Y Hui; Chieko Mineo; Philip W Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.